1. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia
    Xi Tang et al, 2018, Acta Haematologica CrossRef
  2. NEDD4 degrades TUSC2 to promote glioblastoma progression
    Tadas K. Rimkus et al, 2022, Cancer Letters CrossRef
  3. MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling
    Melina M. Musri et al, 2018, American Journal of Respiratory Cell and Molecular Biology CrossRef
  4. Machine learning and bioinformatics approaches for classification and clinical detection of bevacizumab responsive glioblastoma subtypes based on miRNA expression
    Jian Shi, 2022, Scientific Reports CrossRef
  5. MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2
    Hui Hui Xie et al, 2019, Biological Research CrossRef
  6. MicroRNA-197 induces epithelial–mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma
    Nan Zhang et al, 2018, Journal of Genetics CrossRef
  7. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers
    Qian Zhang et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  8. L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer
    Jinlong Chen et al, 2018, Experimental and Therapeutic Medicine CrossRef
  9. MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin
    Zhiwei Liao et al, 2017, Molecular Medicine Reports CrossRef
  10. Circ-EGFR Functions as an Inhibitory Factor in the Malignant Progression of Glioma by Regulating the miR-183-5p/TUSC2 Axis
    Qingdong Guo et al, 2022, Cellular and Molecular Neurobiology CrossRef
  11. MicroRNA-197 Mediates the Overgrowth and Anti-Apoptotic Effects by Downregulating Insulin-Like Growth Factor-Binding Protein-3 During Nephroblastoma Tumorigenesis
    Jinhua Hu et al, 2016, Fetal and Pediatric Pathology CrossRef
  12. Does miR-197 Represent a Valid Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma (HNSCC)? A Systematic Review and Trial Sequential Analysis
    Mario Dioguardi et al, 2022, Journal of Personalized Medicine CrossRef
  13. Micro RNAs mir‐106a, mir‐122 and mir‐197 are increased in severe acute viral hepatitis with coagulopathy
    Lukas Weseslindtner et al, 2016, Liver International CrossRef
  14. Immunohistochemical and molecular evaluation of TUSC2 expression in breast cancer
    Leyla Tekin et al, 2024, Molecular Biology Reports CrossRef
  15. The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
    Raffaela Mariarosaria Mariniello et al, 2020, International Journal of Molecular Sciences CrossRef
  16. MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
    Srikanth Nama et al, 2019, Scientific Reports CrossRef
  17. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR‐106b-5p/TUSC2 axis
    Wu Huang et al, 2020, Human Cell CrossRef
  18. Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications
    Roman Uzhachenko et al, 2022, Cancer Gene Therapy CrossRef
  19. miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2
    Shaoqiang Liang et al, 2017, Experimental and Therapeutic Medicine CrossRef
  20. miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets
    Omidvar Rezaei et al, 2020, Experimental and Molecular Pathology CrossRef
  21. miR-197: A novel biomarker for cancers
    Dan-dan Wang et al, 2016, Gene CrossRef
  22. MicroRNA‑663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2
    Jianying Chen et al, 2019, Molecular Medicine Reports CrossRef
  23. Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy
    Austin Arrigo et al, 2023, Cancers CrossRef
  24. Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
    James S. Brown, 2023, Neuroscience & Biobehavioral Reviews CrossRef
  25. Oncogenic Role of MicroRNA-30b-5p in Glioblastoma Through Targeting Proline-Rich Transmembrane Protein 2
    Zhongjun Li et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef